Increased type III procollagen in serum and skin of patients with amyotrophic lateral sclerosis

Acta Neurologica Scandinavica

Volumn 100, Issue 6, 1999, Pages 377-384

  Ono, Seiitsu ^a   Imai, T ^b   Takahashi, K ^c   Jinnai, K ^c   Shimizu, N ^a   Nagao, K ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Chiba Higashi Hospital   (Japan)

^c Japan   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Immunohistochemistry; Skin; Type III procollagen; Urine

Indexed keywords

PROCOLLAGEN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PATHOPHYSIOLOGY; SKIN DISEASE;

EID: 0032746412     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb01056.x     Document Type: Article

References (37)

1. 1. ONO S, MANNEN T, TOYOKURA Y. Differential diagnosis between amyotrophic lateral sclerosis and spinal muscular atrophy by skin involvement. J Neurol Sci 1989;91:301-10.
2. 2. ONO S, MECHANIC GL, YAMAUCHI M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J Neurol Sci 1990;100:234-7.
3. 3. ONO S, YAMAUCHHI M. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann Neurol 1992;31:305-10.
4. 4. ONO S, YAMAUCHI M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 1992; 42:1535-9.
5. 5. ONO S, TOYOKURA Y, MANNEN T, ISHIBASHI Y. "Delayed return phenomenon" in amyotrophic lateral sclerosis. Acta Neurol Scand 1988;77:102-7.
6. 6. UITTO J, FAZIO MJ. Biology and pathology of the extracellular matrix in dermis. In SOTER NA, BADEN HP, eds. Pathophysiology of dermatologic diseases, 2nd edn. New York: McGraw Hill, 1990;49-67.
7. 7. VUORIO E, DE CROMBRUGGLE B. The family of collagen genes. Annu Rev Biochem 1990;59:837-72.
8. 8. BRUCKNER P, BACHINGER HP, TIMPL R, ENGEL J. Three conformationally distinct domains in the amino-terminal segment of type III procollagen and its rapid triple helix coil leads to end comes from coil transition. Eur J Biochem 1978;90:595-603.
9. 9. HAUKIPURO K, RISTELI L, KAIRALUOMA M, RISTELI J. Aminoterminal propeptide of type III procollagen in healing wound in humans. Ann Surg 1987;206:752-6.
10. 10. BEUKERS R, VAN ZANTEN RA, SCHALM SW. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis. J Hepatol 1992;14:22-9.
11. 11. OIKARINEN A, AUTIO P, KIISTALA U, RISTELI L, RISTELI J. A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol 1992;98:220-5.
12. 12. RISTELI L, RISTELI J. Radioimmunoassays for monitoring connective tissue metabolism. Rheumatology 1986;10: 216-45.
13. 13. RISTELI L, RISTELI J. Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol 1987;145: 381-411.
14. 14. ROHDE H, VARGAS L, HAHN EG, KALBFLEISCH H, BRUGUERA M, TIMPL R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979;9:451-9.
15. 15. NIEMELÄ O, RISTELI L, SOTANIEMI EA, RISTELI J. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum. Clin Chim Acta 1982;124:39-44.
16. 16. HAHN EG. Blood analysis for liver fibrosis. J Hepatol 1984;1:67-73.
17. 17. ONO S, TOYOKURA Y, MANNEN T, ISHIBASHI Y. Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin. Neurology 1986;36:948-56.
18. 18. CAROSCIO JT, COHEN JA, ZAWODNIAK J et al. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis. Neurology 1986;36:141-5.
19. 19. PATTEN BM, HARATI Y, ACOSTA L, JUNG SS, FEIMUS MT. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol 1978;3:303-9.
20. 20. HSU SM, RAINE L, FANGER H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
21. 21. ANNONI G, CARGNEL A, COLOMBO M, HAN EG. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis. J Hepatol 1986;2:379-88.
22. 22. KRIEG, T, LANGER I, GERSTMEIER H et al. Type III collagen aminopeptide levels in serum of patients with progressive systemic scleroderma. J Invest Dermatol 1986;87:788-91.
23. 23. HØRSLEV-PETERSEN K, AMMITZBØLL T, ENGSTRÖM-LAURENT A et al. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites. J Rheumatol 1988;15:460-7.
24. 24. TORRES-SALINAS M, PARÉS A, CABALLERÍA J et al. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986; 90:1241-6.
25. 25. TRINCHET JC, HARTMANN DJ, PATERON D et al. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests. J Hepatol 1991;12:139-44.
26. 26. HOCHWEISS S, FRUCHTMAN S, HAHN EG et al. Increased serum procollagen III aminoterminal peptide in myelofibrosis. Am J Hematol 1983;15:343-51.
27. 27. KIRK JME, BATEMAN ED, HASLAM PL, LAURENT GJ, TURNER-WARWICK M. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax 1984;39:726-32.
28. 28. BOLARTN DM, ASNDY JJ, Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis. Ann Clin Res 1983;15:123-7.
29. 29. MYLLYLÄ R, MYLLYLÄ VV, TOLONEN U, KIVIRIKKO KI. Changes in collagen metabolism in diseased muscle. I. Biochemical studies. Arch Neurol 1982;39:752-5.
30. 30. SIMON LS, KRANE SM, WORTMAN PD, KRANE IM, KOVITZ KL. Serum levels of type I and III procollagen fragments in Paget's disease of bone. J Clin Endocrinol Metab 1984;58:110-20.
31. 31. BOLARIN DM, SAVOLINEN ER, KIVIRIKKO KI. Enzymes of collagen synthesis and type III procollagen amino propeptide in serum from Nigerians with hepato-cellular carcinoma and other malignant diseases. Int J Cancer 1982;29:401-5.
32. 32. DI-CESARE PE, CHEUNG DT, PERELMAN N, LIBAW E, PENG L, NIMINI ME. Alteration of collagen composition and cross-linking in keloid tissues. Matrix 1990;10:172-8.
33. 33. TRIVEDI P, CHEESEMAN P, PORTMANN B, HEGARTY J, MOWAT AP. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest 1985;15:69-74.
34. 34. SHUSTER S, BLACK MM, MCVITIE E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975;93:639-43.
35. 35. RAMSHAW JA. Distribution of type III collagen in bovine skin of various ages. Connect Tissue Res 1986;14:307-14.
36. 36. MAYS PK, BISHOP JE, LAULENT GJ. Age-related changes in the proportion of type I and III collagen. Mech Ageing Dev 1988;45:203-12.
37. 37. SCHWARTZ E, CRUICKSHANK FA, PERLISH JS, FLEISCHMAJER R. Alterations in dermal collagen in ultraviolet irradiated hairless mice. J Invest Dermatol 1989;93:142-6.